Karmanos Cancer Center Launches Lung Cancer Screening ProgramThe Barbara Ann Karmanos Cancer Center is launching a lung cancer screening program for adults with a history of smoking – both current and former smokers.
Karmanos Cancer Center Blood and Marrow Stem Cell Transplant Program Gets Foundadtion AccreditationThe Barbara Ann Karmanos Cancer Center's Blood and Marrow Stem Cell Transplant Program has received full accreditation from the Foundation for the Accreditation of Cellular Therapy
Karmanos Cancer Institute Gets Grant From Farrah Fawcett Foundation For Patient Assistance FundThe Barbara Ann Karmanos Cancer Center has received a $25,000 grant through the Farrah Fawcett Foundation to establish the Farrah Fawcett Fund for Patient Assistance at Karmanos.
Karmanos Cancer Center First In Midwest To Offer Latest Molecular Breast ImagingThe Barbara Ann Karmanos Cancer Center in Detroit is the first hospital in the Midwest to offer the newest molecular breast imaging device – GE Healthcare's Discovery NM750b. This technology makes it possible to detect breast cancer in women considered to be at high-risk, especially those with dense breast tissue.
Karmanos Cancer Center Tracks Patient Flow in Clinic with VersusThe Barbara Ann Karmanos Cancer Center is the first cancer center in Michigan to track and manage patient flow using the Versus Advantages Real-time Locating System at its newly opened Dresner Family Clinic for Hematologic Malignancies & Stem Cell Transplantation.
Free Cancer Screenings Friday In Detroit It's billed as 15 minutes that could save your life.
Karmanos Cancer Center Dedicates Dresner Family ClinicThe Barbara Ann Karmanos Cancer Center dedicated its new Joseph Dresner Family Clinic for Hematologic Malignancies & Stem Cell Transplantation with a ribbon-cutting celebration Thursday.
Karmanos Cancer Institute Gets $3.5M Komen Grant To Treat 'Triple Negative' Breast CancerResearchers at the Barbara Ann Karmanos Cancer Institute will focus on creating better therapies to treat triple negative breast cancer thanks to a $3.5 million grant from Susan G. Komen for the Cure.